ON-DEMAND WEBINAR
Multiomic Integration of the Metabolome to Inform Biological Aging and Precision Medicine in Autism and Asthma
Research into biological age is crucial for improving personalized medicine, preventing age-related diseases, and enhancing overall quality of life by identifying individuals at risk and offering targeted interventions. It can also help optimize aging interventions and alleviate the societal impact of aging populations. However, the challenges are significant, including the complexity of aging, the lack of consensus on biomarkers, the need for long-term studies, individual variability in aging processes, and the integration of multiomic data. In this webinar, Dr. Jessica Lasky-Su will discuss her work developing the OMICmAge.
Leveraging the rich, longitudinal resource of the Mass General Brigham (MGB) Biobank, Dr. Lasky-Su and her team integrated over two decades of electronic health records (EHRs) with multiomic data—including DNA methylation, proteomics, and untargeted metabolomics—to advance the understanding of biological aging and precision medicine. They developed OMICmAge, the first multiomic aging biomarker trained across these complementary omic layers, capturing dimensions of molecular aging that outperform single-omic clocks. It further demonstrates that the metabolome enables the extraction of individual nutritional signatures, which show distinct associations with OMICmAge and other aging biomarkers. Additionally, they were able to highlight novel links between metabolomic features and circulating antibody profiles, suggesting immune-metabolic crosstalk relevant to aging and disease. As a case study in precision medicine, Dr. Lasky-Su will show how metabolite ratios can predict asthma exacerbations and stratify patients likely to respond to anti-IgE biologics, underscoring the metabolome’s value in guiding targeted interventions.
Together, these findings establish the metabolome as a powerful bridge between aging, exposome and clinical outcomes in aging and disease.
In This Webinar You Will Learn:
- How multiomic data, including DNA methylation, proteomics, and metabolomics, advances our understanding of biological aging and precision medicine.
- The development of OMICmAge, the first multiomic aging biomarker that captures molecular aging dimensions beyond traditional single-omic clocks.
- The role of the metabolome in identifying individual nutritional signatures and its connections to aging biomarkers.
- How integrating the exposome with clinical outcomes can revolutionize patient stratification and individualized medicine.
Speakers
”Dr.
Dr. Natasa Giallourou, Ph.D.
Field Metabolomic Scientist at Metabolon
Dr. Natasa Giallourou is a Field Metabolomics Scientist supporting Metabolon’s International Business activities. She provides scientific counsel for metabolomics applications in the biopharma and academic sectors. Natasa obtained her Ph.D. in Metabolomics from the University of Reading and holds an M.Sc. in Nutrition and Health from Wageningen University and a B.Sc. in Biology from the University of Leeds.
Prior to joining Metabolon, Natasa served as a Marie Skłodowska-Curie Postdoctoral Fellow at biobank.cy. Her research projects involved integrating metabolomic data with other omics data in population-based studies, with a focus on identifying biomarkers for complex diseases. She has also worked as a postdoctoral research associate at Imperial College London, where she specialized in utilizing metabolic phenotyping to address global health challenges, particularly in the field of public health nutrition.
Natasa sits on the Board of Directors of the International Metabolomics Society and is also an advisor to the Early-career Member’s Network for young metabolomics scientists.
